These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 17060575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
    Neumann J, Bilzer T.
    Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL, Netherlands Association of Gastroenterologists and Hepatologists.
    Neth J Med; 2008 Feb; 66(7):292-306. PubMed ID: 18663260
    [Abstract] [Full Text] [Related]

  • 7. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL.
    N Engl J Med; 1990 Apr 19; 322(16):1098-105. PubMed ID: 2320079
    [Abstract] [Full Text] [Related]

  • 8. Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients.
    Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM, Wang FS, Lau GK.
    J Viral Hepat; 2009 Feb 19; 16(2):104-12. PubMed ID: 19175882
    [Abstract] [Full Text] [Related]

  • 9. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA.
    Ned Tijdschr Geneeskd; 2008 Jun 21; 152(25):1426-30. PubMed ID: 18624006
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R, Zhang HP, Yu H, Li H, Ling YQ, Hu XQ, Zhu HG.
    Pathol Res Pract; 2008 Jun 21; 204(10):731-42. PubMed ID: 18597951
    [Abstract] [Full Text] [Related]

  • 11. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
    Feng B, Wei L, Chen M, Wang L.
    Microbiol Res; 2008 Jun 21; 163(4):487-92. PubMed ID: 17317127
    [Abstract] [Full Text] [Related]

  • 12. [Muscle granuloma: anatomoclinical correlation and immunohistochemistry in seven cases].
    Fernandez C, Attarian S, Figarella-Branger D, Disdier P, Grob JJ, Pouget J, Pellissier JF.
    Rev Neurol (Paris); 2003 Apr 21; 159(4):425-33. PubMed ID: 12773872
    [Abstract] [Full Text] [Related]

  • 13. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B, Mukhopadhya A, Kurian G.
    J Gastroenterol Hepatol; 2008 Nov 21; 23(11):1734-8. PubMed ID: 18713304
    [Abstract] [Full Text] [Related]

  • 14. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov 21; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 15. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S, Ohtsuka K, Satou T, Furuta T, Kimura M, Hashimoto S.
    Rinsho Byori; 1998 Feb 21; 46(2):168-75. PubMed ID: 9528342
    [Abstract] [Full Text] [Related]

  • 16. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007 Feb 21; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH, Yu SK, Seo YS, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH, Byun KS.
    J Gastroenterol Hepatol; 2007 Aug 21; 22(8):1220-5. PubMed ID: 17532786
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M, Cetin Akhan S, Vahaboğlu H.
    Mikrobiyol Bul; 2008 Apr 21; 42(2):283-91. PubMed ID: 18697426
    [Abstract] [Full Text] [Related]

  • 19. Muscle damage and autoantibody fixation in an experimental model of autoimmune myopathy.
    Losada M, Wangüemert AM, Torres SH, Hernández N, Rivas M, Bravo C, Pulido MM.
    Acta Cient Venez; 2002 Apr 21; 53(4):290-6. PubMed ID: 12945495
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
    Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA.
    AIDS; 2007 Aug 20; 21(13):1701-10. PubMed ID: 17690567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.